These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26565790)

  • 41. Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay.
    Earl R; Sobeski L; Timko D; Markin R
    Clin Chem; 1991 Oct; 37(10 Pt 1):1774-7. PubMed ID: 1914183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous infusion pentobarbital for refractory status epilepticus in children.
    Barberio M; Reiter PD; Kaufman J; Knupp K; Dobyns EL
    J Child Neurol; 2012 Jun; 27(6):721-6. PubMed ID: 22156786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Monitoring of immunosuppressant drugs].
    Rentsch KM
    Ther Umsch; 2008 Sep; 65(9):545-50. PubMed ID: 18791969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Blood-brain barrier--an important factor for distribution of hypnotics and their metabolites in the central nervous system].
    Arnold W
    Beitr Gerichtl Med; 1991; 49():103-10. PubMed ID: 1811485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral hemodynamic effects of pentobarbital coma in head-injured patients.
    Cormio M; Gopinath SP; Valadka A; Robertson CS
    J Neurotrauma; 1999 Oct; 16(10):927-36. PubMed ID: 10547101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of aflatoxin B1 on the sensitivity of the rat central nervous system to pentobarbital-Na racemate.
    Stĕtinová V; Grossmann V; Kvĕtina J; Srámek B
    Pol J Pharmacol; 1995; 47(5):393-9. PubMed ID: 8868130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
    Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid quantification of pentobarbital in serum by fluorescence polarization immunoassay.
    Li PK; Lee JT; Schreiber RM
    Clin Chem; 1984 Feb; 30(2):307-8. PubMed ID: 6692543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury.
    Mellion SA; Bennett KS; Ellsworth GL; Moore K; Riva-Cambrin J; Metzger RR; Bratton SL
    Pediatr Crit Care Med; 2013 Mar; 14(3):239-47. PubMed ID: 23392360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinician ordering practices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory.
    Miyakis S; van Hal SJ; Solvag CJ; Ray J; Marriott D
    Ther Drug Monit; 2010 Oct; 32(5):661-4. PubMed ID: 20720520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic drug monitoring of levetiracetam: comparison of a novel immunoassay with an HPLC method.
    Bianchi V; Arfini C; Vidali M
    Ther Drug Monit; 2014 Oct; 36(5):681-5. PubMed ID: 24577125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
    Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
    Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department.
    von Mach MA; Weber C; Meyer MR; Weilemann LS; Maurer HH; Peters FT
    Ther Drug Monit; 2007 Feb; 29(1):27-39. PubMed ID: 17304147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
    Prokopczyk J; Piekarczyk A; Kaminska E
    Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A suicide involving intraperitoneal injection of pentobarbital.
    Hangartner S; Steiner J; Dussy F; Moeckli R; Gerlach K; Briellmann T
    Int J Legal Med; 2016 Sep; 130(5):1217-22. PubMed ID: 26174446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Important role of population pharmacokinetic/pharmacodynamic modeling in pediatric therapeutics.
    Vinks AA
    J Pediatr; 2011 Sep; 159(3):361-3. PubMed ID: 21764403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.